Insights

The Power of Patent Licensing: Unlocking Innovation and Access to Medicines Patent licensing agreements have become a crucial tool in […]
Source

In the fiercely competitive pharmaceutical industry, securing and enforcing patents is crucial for recouping the massive investments required to bring […]
Source

Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs. These groups, […]
Source

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […]
Source

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […]
Source

Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […]
Source

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […]
Source

To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […]
Source

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […]
Source

In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]
Source